Jiayan Xu

1PUBLICATIONS
0CO-AUTHORS
Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 03, 2025
A post-marketing disproportionality analysis of the safety of ribociclib based on the FDA Adverse Event Reporting System.

Jiayan Xu, Ruo Wang, Kunwei Shen

Pageof 1

Frequent Collaborators